1. Mancuso, D.J.; Tuley, E.A.; Westfield, L.A.; Worrall, N.K.; Shelton-Inoles, B.B.; Sorace, J.M.; Alevy, Y.G.; Sadler, J.E. Structure of the gene for human von Willebrand factor. J. Biol. Chem. 1989, 264, 19514-19527.

2. Jaffe, E.A.; Hoyer, L.W.; Nachman, R.L. Synthesis of von

Willebrand factor by cultured human endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 1974, 71, 1906-1909.

3. Tuddenham, E.G.D.; Lane, R.S.; Rotblot, F.; Johason, A.J.; Snape, J.; Middleton, S.; Kernoff, P.B.A. Response to infusion of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. Br. J. Haematol. 1982, 52, 259-267.

4. Titani, K.; Kumar, S.; Takio, K.; Ericsson, L.H.; Wade, R.D.; Ashida, K.; Walsh, K.A.; Chopek, M.W.; Sadler, J.E.; Fujikawa, K. Amino acid sequence of human von Willebrand factor. Biochemistry 1986, 25, 3171-3184.

5. Wagner, D.D.; Mader, Vj. Biosynthesis of von Willebrand protein by human endothelial cells: Processing steps and their intracellular localization. J. Cell Biol. 1984, 99, 2123-2130.

6. Roth, G.J.; Titani, K.; Hoyer, L.W.; Hickey, M.J. Localization of binding sites within human von Willebrand factor for monomeric type III collagen. Biochemistry 1986, 25, 8357-8361.

7. Ruggeri, Z.M.; Zimmerman, T.S. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 1981, 57, 1140-1143.

8. Sadler, J.E. A revised classification of von Willebrand disease. Thromb. Haemost. 1994, 71, 520-525.

9. Goodeve, A.; Peake, I.; Hashemi, M.; Al-Buhairan, A.; Castaman, G.; Barronciani, L.; Battle, J.; Ribba, A.-S.; Eikenboom, J.; Oyen, F.; Christianansen, K.; Habart, D.; Lethagen, S.; Pasi, J.K.; Guilliatt, A.; Surdhar, S.; Enayat, M.S.; Lester, W. Mutation analysis in type 1 von Willebrand disease patients entered in the multicenter MCMDM-1VWD study. In XVIII Congress of the International Society on Thrombosis and Haemostasis, 2003, Birmingham, UK. J. Thromb. Haemost. July 1, 2003; 1 Supplement. (ISSN 1740 3340). Abs No: 0C075.

10. Abuznadah, A.M.; Gursel, T.; Ingerslev, J.; Nesbitt, I.M.; Peake, I.R.; Goodeve, A.C. Mutational analysis of the von Willebrand factor gene in 27 families from Turkey with von Willebrand disease. Thromb. Haemost. 1999. Supp. Ab. 887.

11. Baronciani, L.; Cozzi, G.; Canciani, M.T.; Peyvandi, F.; Srivastva, A.; Federici, A.B.; Mannucci, P.M. Molecular defects in type 3 von Willebrand disease: Updated results from 40 multiethnic patients. Blood Cells Mol. Diseases 2003, 30, 264-270.

12. Surdhar, G.K.; Enayat, M.S.; Lawson, S.; Williams, M.D.; Hill, F.G.H. Homozygous gene conversion in von Willebrand factor gene as a cause of type 3 von Willebrand disease and predisposition to inhibitor development. Blood 2001, 98, 248-250.

13. Peake, I.R.; Bowen, D.; Bignell, P.; Liddell, M.B.; Sadler, J.E.; Standen, G.; Bloom, A.L. Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene. Blood 1990, 76, 555-561.

14. Eikenboom, J.C.J.; Castaman, G.; Vos, H.L.; Bertina, R.M. Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin. Thromb. Haemost. 1998, 79, 709 -717.

15. Inbal, A.; Selegsjohn, U.; Kornbrot, N.; Brenner, B.; Harison, P.; Randi, A.; Rabinowitz, I.; Sadler, J.E. Characterization of three mutations causing von Willebrand disease type IIA in five unrelated families. Thromb. Haemost. 1992, 67, 618-622.

16. Lyons, S.E.; Bruck, M.E.; Bowie, J.E.W.; Ginsburg, D. Impaired intracellular transport produced by a subset of 21. type IIA von Willebrand disease mutations. J. Biol. Chem.

1992, 267, 4424-4430.

17. Furlan, M.; Robles, R.; Lammle, B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996, 87, 4223 -4234.

18. Dent, J.A.; Berkowitz, S.D.; Ware, J.; Kasper, C.K.; 22. Ruggeri, Z. Identification of a cleavage site directing the immunochemical detection of a molecular abnormalities in type IIA von Willebrand factor. Proc. Natl. Acad. Sci. U. S. A. 1990, 87, 6306-6310.

19. Manucci, P.M.; Lombardi, R.; Castaman, G.; Dent, J.A.; 23. Lattuada, A.; Rodrghiero, F.; Zimmermann, T.S. Von Willebrand disease ''Vincenza'' with-larger-than normal (supranormal) von Willebrand factor multimers. Blood

20. Schneppenheim, R.; Federici, A.B.; Budde, U.; Castaman,

G.; Drewke, E.; Krey, S.; Mannucci, P.M.; Riesen, G.; Rodeghiero, F.; Zieger, B.; Zimmerman, R. Von Willebrand disease type 2m ''Vicenza'' in Italian and German patients: Identification of the first candidate mutation (G3864A; R1205H) in 8 families. Thromb. Haemost. 2000, 82, 136-140.

Mazurier, C.; Dieval, J.; Jorieux, S.; Delobel, J.; Goudemand, M. A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 1990, 75, 2026.

Eikenboom, J.C.J.; Castaman, G.; Kamphuisen, P.W.; Bertina, R.M. Factor VIII/von Willebrand factor ratio in healthy and in heterozygous carriers of VWF null allele and von Willebrand type 2 N mutations. Thromb. Haemost. 1999. Supp. Ab 2168.

Allen, S.; Abuzenadah, A.M.; Blagg, J.; Hinks, S.; Nesbitt, I.M.; Daly, M.E.; Goodeve, A.; Gursel, T.; Ingerslov, J.; Peake, I.R. Cys788Arg and Cys1225Gly mutations in von Willebrand factor result in combined type 1 and type N von Willebrand disease. Thromb. Haemost. 1999. Supp. Ab 2167.

Getting Started With Dumbbells

Getting Started With Dumbbells

The use of dumbbells gives you a much more comprehensive strengthening effect because the workout engages your stabilizer muscles, in addition to the muscle you may be pin-pointing. Without all of the belts and artificial stabilizers of a machine, you also engage your core muscles, which are your body's natural stabilizers.

Get My Free Ebook

Post a comment